Increasingly complex molecular analysis is the backbone of every development in the life science continuum. At BLINK we are developing technology that puts the power of creation in more hands and places molecular analysis tools in reach for more users in areas like life science research, biotechnology, environmental testing, agriculture, veterinary medicine and in-vitro-diagnostics.
Our mission is to:
Accelerate product development
Lower barriers to introducing novel assays into routine use
Reduce development and deployment cost
Cooperation is always a win for the partners involved. If you want to become our partner, get in touch and let's explore what we can achieve together.
Our business model centers around the licensing of our intellectual property rights to the best commercial partners for the respective markets. If you are a market segment leader and are interested to integrate nanoreactor beads into your offering, we would love to hear from you.
BLINK was founded in 2015 by Eugen Ermantraut, Torsten Schulz and Thomas Ellinger. Many members of the BLINK team have previously developed, built and deployed some of the most advanced point-of-care products currently available. BLINK is taking the next step towards creating a holistic product platform for near patient use.